No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Neurotensin Receptor Agonists (NRAs) are a class of drugs used to treat disorders of the Central Nervous System (CNS). They act on the Neurotensin Receptor (NTR) to modulate the activity of neurons in the brain and spinal cord. NRAs are used to treat a variety of CNS disorders, including schizophrenia, depression, anxiety, and addiction. They are also used to treat pain, epilepsy, and Parkinson's disease. NRAs are generally well-tolerated and have few side effects.
The Neurotensin Receptor Agonist market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of CNS disorders, as well as the development of new and improved NRAs. The market is expected to continue to grow in the coming years, as more NRAs are developed and approved for use.
Some companies in the Neurotensin Receptor Agonist market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
